Studies have shown that an elevated plasma S100A1 level is a significant predictor of ST-segment elevation myocardial infarction, while there is reduced S100A1 expression in failing and hypertrophic heart tissues (Fan et al., 2019). This evidence concerns the gene S100A1 and myocardial infarction.